Question · asked by 1 review
NSAIDs vs placebo: QoL
- Population
- participants with chronic CME (≥ 4 months) following cataract surgery
- Intervention
- NSAIDs
- Comparison
- placebo
- Outcome
- QoL
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
NSAID vs placebo Change in QoL · participants with chronic CME (≥ 4 months) following cataract surgery The review found no eligible studies for this question. Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery (2022) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- NSAIDs vs active control · participants with acute or chronic CME following cataract surgery · 1 review
- NSAIDs vs placebo or active control · participants with acute CME (< 4 months) following cataract surgery · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.